<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27629939</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2016</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Methylcrotonoyl-CoA carboxylase 1 potentiates RLR-induced NF-&#x3ba;B signaling by targeting MAVS complex.</ArticleTitle><Pagination><StartPage>33557</StartPage><MedlinePgn>33557</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">33557</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep33557</ELocationID><Abstract><AbstractText>RNA virus infections are detected by the RIG-I family of receptors, which signal through the adaptor molecule mitochondrial antiviral signaling (MAVS). MAVS then recruits the adaptor's tumor necrosis factor receptor-associated factor (TRAF) 3 and TRAF6, which in turn activate IRF3 and NF-&#x3ba;B, respectively, to induce interferons (IFNs) and inflammatory responses. Here we show that the biotin-containing enzyme methylcrotonoyl-CoA carboxylase 1 (MCCC1) enhances virus-induced, MAVS-mediated IFN and inflammatory cytokine expression through the NF-&#x3ba;B signaling pathway. MCCC1 knockdown strongly inhibits induction of IFNs and inflammatory cytokines. Furthermore, MCCC1 shows extensive antiviral activity toward RNA viruses, including influenza A virus, human enterovirus 71, and vesicular stomatitis virus. Here, we have elucidated the mechanism underlying MCCC1-mediated inhibition of viral replication. MCCC1 interacts with MAVS and components of the MAVS signalosome and contributes to enhanced production of type I IFNs and pro-inflammatory cytokines by promoting phosphorylation of the I&#x3ba;B kinase (IKK) complex and NF-&#x3ba;B inhibitor-&#x3b1; (I&#x3ba;B&#x3b1;), as well as NF-&#x3ba;B nuclear translocation. This process leads to activation of IFNs and cytokine expression and subsequent activation of IFN-stimulated genes, including double-stranded RNA-dependent protein kinase PKR and myxovirus resistance protein 1. These findings demonstrate that MCCC1 plays an essential role in virus-triggered, MAVS-mediated activation of NF-&#x3ba;B signaling.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Zhongying</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Zhangchuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yaqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiaodan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Nanfang</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C505371">MAVS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048029">TNF Receptor-Associated Factor 6</NameOfSubstance></Chemical><Chemical><RegistryNumber>139874-52-5</RegistryNumber><NameOfSubstance UI="D000072000">NF-KappaB Inhibitor alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000071457">DEAD Box Protein 58</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.4.-</RegistryNumber><NameOfSubstance UI="D019735">Carbon-Carbon Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.4.1.4</RegistryNumber><NameOfSubstance UI="C021573">methylcrotonoyl-CoA carboxylase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000072283" MajorTopicYN="N">A549 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019735" MajorTopicYN="N">Carbon-Carbon Ligases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071457" MajorTopicYN="N">DEAD Box Protein 58</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072000" MajorTopicYN="N">NF-KappaB Inhibitor alpha</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048029" MajorTopicYN="N">TNF Receptor-Associated Factor 6</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27629939</ArticleId><ArticleId IdType="pmc">PMC5024325</ArticleId><ArticleId IdType="doi">10.1038/srep33557</ArticleId><ArticleId IdType="pii">srep33557</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Randall R. E. &amp; Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. The Journal of general virology 89, 1&#x2013;47, doi: 10.1099/vir.0.83391-0 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83391-0</ArticleId><ArticleId IdType="pubmed">18089727</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M. S. &amp; Lee J. O. Structures of the toll-like receptor family and its ligand complexes. Immunity 29, 182&#x2013;191, doi: 10.1016/j.immuni.2008.07.007 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2008.07.007</ArticleId><ArticleId IdType="pubmed">18701082</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K. &amp; Akira S. Toll-like receptors in innate immunity. International immunology 17, 1&#x2013;14, doi: 10.1093/intimm/dxh186 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxh186</ArticleId><ArticleId IdType="pubmed">15585605</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T. &amp; Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637&#x2013;650, doi: 10.1016/j.immuni.2011.05.006 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.05.006</ArticleId><ArticleId IdType="pubmed">21616434</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature immunology 5, 730&#x2013;737, doi: 10.1038/ni1087 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1087</ArticleId><ArticleId IdType="pubmed">15208624</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T. et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proceedings of the National Academy of Sciences of the United States of America 104, 582&#x2013;587, doi: 10.1073/pnas.0606699104 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0606699104</ArticleId><ArticleId IdType="pmc">PMC1766428</ArticleId><ArticleId IdType="pubmed">17190814</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nature immunology 6, 981&#x2013;988, doi: 10.1038/ni1243 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1243</ArticleId><ArticleId IdType="pubmed">16127453</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L. G. et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Molecular cell 19, 727&#x2013;740, doi: 10.1016/j.molcel.2005.08.014 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2005.08.014</ArticleId><ArticleId IdType="pubmed">16153868</ArticleId></ArticleIdList></Reference><Reference><Citation>Meylan E. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167&#x2013;1172, doi: 10.1038/nature04193 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04193</ArticleId><ArticleId IdType="pubmed">16177806</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth R. B., Sun L., Ea C. K. &amp; Chen Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122, 669&#x2013;682, doi: 10.1016/j.cell.2005.08.012 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.08.012</ArticleId><ArticleId IdType="pubmed">16125763</ArticleId></ArticleIdList></Reference><Reference><Citation>Belgnaoui S. M., Paz S. &amp; Hiscott J. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Current opinion in immunology 23, 564&#x2013;572, doi: 10.1016/j.coi.2011.08.001 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2011.08.001</ArticleId><ArticleId IdType="pubmed">21865020</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha S. K. et al. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. The EMBO journal 25, 3257&#x2013;3263, doi: 10.1038/sj.emboj.7601220 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7601220</ArticleId><ArticleId IdType="pmc">PMC1523175</ArticleId><ArticleId IdType="pubmed">16858409</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K. A. et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nature immunology 4, 491&#x2013;496, doi: 10.1038/ni921 (2003).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni921</ArticleId><ArticleId IdType="pubmed">12692549</ArticleId></ArticleIdList></Reference><Reference><Citation>Durbin J. E. et al. Type I IFN modulates innate and specific antiviral immunity. Journal of immunology 164, 4220&#x2013;4228 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10754318</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy D. E. &amp; Garcia-Sastre A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine &amp; growth factor reviews 12, 143&#x2013;156 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11325598</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy D. E. &amp; Marie I. J. RIGging an antiviral defense&#x2013;it&#x2019;s in the CARDs. Nature immunology 5, 699&#x2013;701, doi: 10.1038/ni0704-699 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni0704-699</ArticleId><ArticleId IdType="pubmed">15224097</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M., Onomoto K., Jogi M., Akaboshi T. &amp; Fujita T. Viral RNA detection by RIG-I-like receptors. Current opinion in immunology 32, 48&#x2013;53, doi: 10.1016/j.coi.2014.12.012 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2014.12.012</ArticleId><ArticleId IdType="pubmed">25594890</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S. et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630, doi: 10.1126/science.aaa2630 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa2630</ArticleId><ArticleId IdType="pubmed">25636800</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyzewski Z., Gregorczyk K. P., Struzik J., Niemialtowski M. &amp; Szulc-Dabrowska L. MAVS protein and its interactions with hepatitis A, B and C viruses. Postepy higieny i medycyny doswiadczalnej 70, 14&#x2013;24, doi: 10.5604/17322693.1192925 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.5604/17322693.1192925</ArticleId><ArticleId IdType="pubmed">26864061</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y. et al. An autoinhibitory mechanism modulates MAVS activity in antiviral innate immune response. Nature communications 6, 7811, doi: 10.1038/ncomms8811 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8811</ArticleId><ArticleId IdType="pmc">PMC4518314</ArticleId><ArticleId IdType="pubmed">26183716</ArticleId></ArticleIdList></Reference><Reference><Citation>Obata K. et al. Human biotin-containing subunit of 3-methylcrotonyl-CoA carboxylase gene (MCCA): cDNA sequence, genomic organization, localization to chromosomal band 3q27, and expression. Genomics 72, 145&#x2013;152, doi: 10.1006/geno.2000.6366 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/geno.2000.6366</ArticleId><ArticleId IdType="pubmed">11401427</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgartner M. R. et al. The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency. The Journal of clinical investigation 107, 495&#x2013;504, doi: 10.1172/JCI11948 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI11948</ArticleId><ArticleId IdType="pmc">PMC199271</ArticleId><ArticleId IdType="pubmed">11181649</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen K. V., Naviaux R. K., Patra S., Barshop B. A. &amp; Nyhan W. L. Novel mutations in the human MCCA and MCCB gene causing methylcrotonylglycinuria. Molecular genetics and metabolism 102, 218&#x2013;221, doi: 10.1016/j.ymgme.2010.10.008 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2010.10.008</ArticleId><ArticleId IdType="pubmed">21071250</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolau B. J., Ohlrogge J. B. &amp; Wurtele E. S. Plant biotin-containing carboxylases. Archives of biochemistry and biophysics 414, 211&#x2013;222 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12781773</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X. et al. Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-i receptor in breast cancer cells resistant to herceptin. Cancer research 70, 1204&#x2013;1214, doi: 10.1158/0008-5472.CAN-09-3321 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-09-3321</ArticleId><ArticleId IdType="pubmed">20103628</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L. et al. Down-regulation of miR-301a suppresses pro-inflammatory cytokines in Toll-like receptor-triggered macrophages. Immunology 140, 314&#x2013;322, doi: 10.1111/imm.12139 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12139</ArticleId><ArticleId IdType="pmc">PMC3800436</ArticleId><ArticleId IdType="pubmed">23808420</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauli E. K. et al. Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS pathogens 4, e1000196, doi: 10.1371/journal.ppat.1000196 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000196</ArticleId><ArticleId IdType="pmc">PMC2572141</ArticleId><ArticleId IdType="pubmed">18989459</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott J. et al. New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells. PloS one 5, e11159, doi: 10.1371/journal.pone.0011159 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011159</ArticleId><ArticleId IdType="pmc">PMC2887373</ArticleId><ArticleId IdType="pubmed">20567522</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue X. et al. Induction of cyclooxygenase-2 expression by hepatitis B virus depends on demethylation-associated recruitment of transcription factors to the promoter. Virology journal 8, 118, doi: 10.1186/1743-422X-8-118 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-118</ArticleId><ArticleId IdType="pmc">PMC3066118</ArticleId><ArticleId IdType="pubmed">21401943</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakhaei P., Genin P., Civas A. &amp; Hiscott J. RIG-I-like receptors: sensing and responding to RNA virus infection. Seminars in immunology 21, 215&#x2013;222, doi: 10.1016/j.smim.2009.05.001 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2009.05.001</ArticleId><ArticleId IdType="pubmed">19539500</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25, 6685&#x2013;6705, doi: 10.1038/sj.onc.1209934 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209934</ArticleId><ArticleId IdType="pubmed">17072322</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden M. S., West A. P. &amp; Ghosh S. NF-kappaB and the immune response. Oncogene 25, 6758&#x2013;6780, doi: 10.1038/sj.onc.1209943 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209943</ArticleId><ArticleId IdType="pubmed">17072327</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L. Structure and function of biotin-dependent carboxylases. Cellular and molecular life sciences: CMLS 70, 863&#x2013;891, doi: 10.1007/s00018-012-1096-0 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-012-1096-0</ArticleId><ArticleId IdType="pmc">PMC3508090</ArticleId><ArticleId IdType="pubmed">22869039</ArticleId></ArticleIdList></Reference><Reference><Citation>Jitrapakdee S. &amp; Wallace J. C. The biotin enzyme family: conserved structural motifs and domain rearrangements. Current protein &amp; peptide science 4, 217&#x2013;229 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12769720</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallardo M. E. et al. The molecular basis of 3-methylcrotonylglycinuria, a disorder of leucine catabolism. American journal of human genetics 68, 334&#x2013;346, doi: 10.1086/318202 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318202</ArticleId><ArticleId IdType="pmc">PMC1235267</ArticleId><ArticleId IdType="pubmed">11170888</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzinger A. et al. Cloning of the human MCCA and MCCB genes and mutations therein reveal the molecular cause of 3-methylcrotonyl-CoA: carboxylase deficiency. Human molecular genetics 10, 1299&#x2013;1306 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11406611</ArticleId></ArticleIdList></Reference><Reference><Citation>Desviat L. R. et al. Functional analysis of MCCA and MCCB mutations causing methylcrotonylglycinuria. Molecular genetics and metabolism 80, 315&#x2013;320, doi: 10.1016/S1096-7192(03)00130-6 (2003).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1096-7192(03)00130-6</ArticleId><ArticleId IdType="pubmed">14680978</ArticleId></ArticleIdList></Reference><Reference><Citation>Stadler S. C. et al. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Human mutation 27, 748&#x2013;759, doi: 10.1002/humu.20349 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.20349</ArticleId><ArticleId IdType="pubmed">16835865</ArticleId></ArticleIdList></Reference><Reference><Citation>Uematsu M. et al. Novel mutations in five Japanese patients with 3-methylcrotonyl-CoA carboxylase deficiency. Journal of human genetics 52, 1040&#x2013;1043, doi: 10.1007/s10038-007-0211-9 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10038-007-0211-9</ArticleId><ArticleId IdType="pubmed">17968484</ArticleId></ArticleIdList></Reference><Reference><Citation>Rips J. et al. Primary and maternal 3-methylcrotonyl-CoA carboxylase deficiency: insights from the Israel newborn screening program. Journal of inherited metabolic disease 39, 211&#x2013;217, doi: 10.1007/s10545-015-9899-4 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-015-9899-4</ArticleId><ArticleId IdType="pubmed">26566957</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L. et al. Identification of eight novel mutations and transcript analysis of two splicing mutations in Chinese newborns with MCC deficiency. Clinical genetics 88, 484&#x2013;488, doi: 10.1111/cge.12535 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.12535</ArticleId><ArticleId IdType="pubmed">25382614</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J. L., Zhu J., Sarkar S. N. &amp; Coyne C. B. Regulation of mitochondrial antiviral signaling (MAVS) expression and signaling by the mitochondria-associated endoplasmic reticulum membrane (MAM) protein Gp78. The Journal of biological chemistry 289, 1604&#x2013;1616, doi: 10.1074/jbc.M113.520254 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.520254</ArticleId><ArticleId IdType="pmc">PMC3894340</ArticleId><ArticleId IdType="pubmed">24285545</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P. et al. UBXN1 interferes with Rig-I-like receptor-mediated antiviral immune response by targeting MAVS. Cell reports 3, 1057&#x2013;1070, doi: 10.1016/j.celrep.2013.02.027 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.02.027</ArticleId><ArticleId IdType="pmc">PMC3707122</ArticleId><ArticleId IdType="pubmed">23545497</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia P. et al. IRTKS negatively regulates antiviral immunity through PCBP2 sumoylation-mediated MAVS degradation. Nature communications 6, 8132, doi: 10.1038/ncomms9132 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9132</ArticleId><ArticleId IdType="pmc">PMC4569712</ArticleId><ArticleId IdType="pubmed">26348439</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell A. M. &amp; Gale M. Jr. RIG-I in RNA virus recognition. Virology 479&#x2013;480, 110&#x2013;121, doi: 10.1016/j.virol.2015.02.017 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.02.017</ArticleId><ArticleId IdType="pmc">PMC4424084</ArticleId><ArticleId IdType="pubmed">25749629</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo Y. M. et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. Journal of virology 82, 335&#x2013;345, doi: 10.1128/JVI.01080-07 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01080-07</ArticleId><ArticleId IdType="pmc">PMC2224404</ArticleId><ArticleId IdType="pubmed">17942531</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei C. Q. et al. ECSIT bridges RIG-I-like receptors to VISA in signaling events of innate antiviral responses. Journal of innate immunity 7, 153&#x2013;164, doi: 10.1159/000365971 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000365971</ArticleId><ArticleId IdType="pmc">PMC6738808</ArticleId><ArticleId IdType="pubmed">25228397</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X. Y., Wei B., Shi H. X., Shan Y. F. &amp; Wang C. Tom70 mediates activation of interferon regulatory factor 3 on mitochondria. Cell research 20, 994&#x2013;1011, doi: 10.1038/cr.2010.103 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2010.103</ArticleId><ArticleId IdType="pubmed">20628368</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong B. et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29, 538&#x2013;550, doi: 10.1016/j.immuni.2008.09.003 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2008.09.003</ArticleId><ArticleId IdType="pubmed">18818105</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa H. &amp; Barber G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674&#x2013;678, doi: 10.1038/nature07317 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07317</ArticleId><ArticleId IdType="pmc">PMC2804933</ArticleId><ArticleId IdType="pubmed">18724357</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng N. et al. Inducible Major Vault Protein Plays a Pivotal Role in Double-Stranded RNA- or Virus-Induced Proinflammatory Response. Journal of immunology, doi: 10.4049/jimmunol.1501481 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501481</ArticleId><ArticleId IdType="pubmed">26843330</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y. et al. Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, IL-29, IL-8, and cyclooxygenase-2. Journal of immunology 187, 4844&#x2013;4860, doi: 10.4049/jimmunol.1100998 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100998</ArticleId><ArticleId IdType="pubmed">21957142</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S. et al. Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon. Hepatology 56, 57&#x2013;66, doi: 10.1002/hep.25642 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.25642</ArticleId><ArticleId IdType="pubmed">22318991</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushima-Miyagi T. et al. TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles. Clinical cancer research: an official journal of the American Association for Cancer Research 18, 6271&#x2013;6283, doi: 10.1158/1078-0432.CCR-12-1595 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-12-1595</ArticleId><ArticleId IdType="pubmed">23014529</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L. et al. Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signaling. The Journal of biological chemistry 287, 11899&#x2013;11910, doi: 10.1074/jbc.M111.308064 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.308064</ArticleId><ArticleId IdType="pmc">PMC3320938</ArticleId><ArticleId IdType="pubmed">22343630</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q. et al. Soluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses. Journal of virology 87, 11244&#x2013;11254, doi: 10.1128/JVI.01248-13 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01248-13</ArticleId><ArticleId IdType="pmc">PMC3807281</ArticleId><ArticleId IdType="pubmed">23946454</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhtar M. M. et al. Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription. The international journal of biochemistry &amp; cell biology 41, 554&#x2013;560, doi: 10.1016/j.biocel.2008.07.001 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2008.07.001</ArticleId><ArticleId IdType="pubmed">18687409</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W. et al. Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PloS one 3, e1985, doi: 10.1371/journal.pone.0001985 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001985</ArticleId><ArticleId IdType="pmc">PMC2288676</ArticleId><ArticleId IdType="pubmed">18414668</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L. et al. Identification of RNA helicase A as a cellular factor that interacts with influenza A virus NS1 protein and its role in the virus life cycle. Journal of virology 86, 1942&#x2013;1954, doi: 10.1128/JVI.06362-11 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06362-11</ArticleId><ArticleId IdType="pmc">PMC3302408</ArticleId><ArticleId IdType="pubmed">22171255</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>